Cutting edge: TCR contacts as anchors: Effects on affinity and HLA-DM stability

被引:17
作者
Anderson, MW
Gorski, J
机构
[1] Ctr Blood SE Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA
[2] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53201 USA
关键词
D O I
10.4049/jimmunol.171.11.5683
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peptides presented via the class II MHC (MHCII) pathway are selected based on affinity for MHCII and stability in the presence of HLA-DM. Currently, epitope selection is thought to be controlled by the ability of peptide to sequester "anchor" residues into pockets in the MHCII Residues exhibiting higher levels of solvent accessibility have been shown to contact TCR, but their roles in affinity and complex stability have not been directly studied. Using the HLA-DR1-hinding influenza peptide, hemagglutinin (306-318), as a model, we show that side chain substitutions at these positions influence affinity and HLA-DM stability. Multiple substitutions reduce affinity to a greater extent than the loss of the major P1 anchor residue. We propose that these effects may be mediated through the H-bond network. These results demonstrate the importance of solvent-exposed residues in epitope selection and blur the distinctions between anchor and TCR contact residues.
引用
收藏
页码:5683 / 5687
页数:5
相关论文
共 32 条
[1]   Nonclassical MHC class II molecules [J].
Alfonso, C ;
Karlsson, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :113-+
[2]   The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues [J].
Arnold, PY ;
La Gruta, NL ;
Miller, T ;
Vignali, KM ;
Adams, PS ;
Woodland, DL ;
Vignali, DAA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :739-749
[3]   Structural factors contributing to DM susceptibility of MHC class II/Peptide complexes [J].
Belmares, MP ;
Busch, R ;
Wucherpfennig, KW ;
McConnell, HM ;
Mellins, ED .
JOURNAL OF IMMUNOLOGY, 2002, 169 (09) :5109-5117
[4]   T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage [J].
Carson, RT ;
Vignali, KM ;
Woodland, DL ;
Vignali, DAA .
IMMUNITY, 1997, 7 (03) :387-399
[5]  
DeLano W., 2004, The Pymol Molecular Graphics System Version 1.0
[6]   Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules [J].
Falk, K ;
Lau, JM ;
Santambrogio, L ;
Esteban, VM ;
Puentes, F ;
Rötzschke, O ;
Strominger, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) :2709-2715
[7]   HIGH-AFFINITY BINDING OF SHORT PEPTIDES TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES BY ANCHOR COMBINATIONS [J].
HAMMER, J ;
BELUNIS, C ;
BOLIN, D ;
PAPADOPOULOS, J ;
WALSKY, R ;
HIGELIN, J ;
DANHO, W ;
SINIGAGLIA, F ;
NAGY, ZA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4456-4460
[8]   IDENTIFICATION OF A MOTIF FOR HLA-DR1 BINDING PEPTIDES USING M13 DISPLAY LIBRARIES [J].
HAMMER, J ;
TAKACS, B ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1007-1013
[9]   Structure of a complex of the human α/β T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401):: Insight into TCR cross-restriction and alloreactivity [J].
Hennecke, J ;
Wiley, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :571-581
[10]   Structure of a covalently stabilized complex of a human αβ T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1 [J].
Hennecke, J ;
Carfi, A ;
Wiley, DC .
EMBO JOURNAL, 2000, 19 (21) :5611-5624